Hui-Wen Liu

Hui-Wen Liu

Auto-generated profile, based on publicly available information

Hui-Wen Liu

School of Mechanical Engineering, Korea University, Seoul, 02841, Republic of Korea

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2026 in Science Advances
Verified
Journal Article
Closed access
JKJonghun Kim
Jonghun Kim
MCMu Seog Choe
Mu Seog Choe
WYWoo Sub Yang
Woo Sub Yang
CLCynthia Lo
Cynthia Lo
HLHui-Wen Liu
Hui-Wen Liu
IPIn-Hyun Park
In-Hyun Park
Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and intellectual disability (ID), are genetically heterogeneous. DEAF1 has emerged as a key NDD risk gene, with pathogenic variants linked to DEAF1-associated neurodevelopmental disorder (DAND), but its role in human neurodevelopment remains unclear. Human cortical organoids (hCOs) provide a physiologically relevant model that recapitulates fetal brain development with an authentic human genetic background. Here, we show that a DEAF1 mutation in human embryonic stem cells disrupts chromatin accessibility at neuronal gene loci, leading to significant transcriptional alterations. In hCOs, this mutation results in aberrant progenitor proliferation, disrupted cortical lamination, and impaired neuronal differentiation. Furthermore, we identify WNT signaling, TGFβ superfamily signaling, and cell cycle regulation as commonly dysregulated pathways across multiple ASD-associated genetic perturbations. Pharmacological inhibition of WNT signaling with a Porcupine inhibitor partially rescues phenotypic defects in DEAF1-mutant hCOs. Our findings identify DEAF1 as a critical regulator of neurodevelopment and support pathway-targeted, mutation-independent therapeutic strategies for ASD and related disorders.

4 September 2026 in Advanced Materials
Verified
Journal Article
Open access
PDF file
JAJinchul Ahn
Jinchul Ahn
MKMin‐Seop Kim
Min‐Seop Kim
JKJu‐Hee Kim
Ju‐Hee Kim
SKSeok‐Hyeon Kang
Seok‐Hyeon Kang
DLDain Lee
Dain Lee
SCSeok Chung
Seok Chung
In vitro models of the human neuromuscular system recapitulate key features of neuromuscular connectivity and are increasingly used to study disease mechanisms. However, activity‐dependent adaptation and the contribution of endothelial cells (ECs) remain incompletely represented in vitro. Here, we establish a bottom‐up, microchip‐based method that supports motor innervation of three‐dimensional (3D) human muscle and permits local or bath application of defined chemical stimuli. The same architecture also supports endothelial ingrowth, producing myobundles with concurrent neural and endothelial integration. Repeated local L‐glutamate stimulation induced structural, metabolic, and transcriptional changes associated with activity‐dependent muscle adaptation, whereas high‐glucose exposure produced a distinct, largely opposing response. Addition of ECs further altered calcium dynamics in motor neurons (MNs) and innervated muscle fibers. This modular method enables controlled investigation of responses to neural, metabolic, and endothelial cues in engineered human neuromuscular system.